FindTrial
Sign In

To Study Effect Of Krishna Til And Guda Modak In Anartava For Commencement Of Menses

An Open Label Single Arm Clinical Study On Krishna Til And Guda Modak In Anartava with respect to Withdrawal Bleeding.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052766
Enrollment
30
Registered
2023-05-17
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N911- Secondary amenorrhea Health Condition 2: N911- Secondary amenorrhea

Interventions

None listed

Sponsors

SANE GURUJI AROGYA KENDRA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients Suffering From Typical Lakshanas Of Anartava, Having Amenorrhea Of More Than 35 Days Without Pregnancy. 2.Amenorrhea Irrespective Of Pcod/Pcos Without Pregnancy.

Exclusion criteria

Exclusion criteria: 1.Pregnancy 2.Primary Amenorrhea 3.Malignancy Of Genital Tract 4.Drug Allergy 5.Systemic Diseases-Htn,Dm,Tb,Hiv 6.Patient On Oral Contraceptives ,Iucds

Design outcomes

Primary

MeasureTime frame
To Study The Effect Of Krishna Til And Guda Modak In Anartava With Respect To Withdrawal Bleeding.Timepoint: Treatment Will Be Given For 7 Days. Patient Will Be Assessed On Day 1 To Day 7, If Menses Not Commenced Then From Day 8 To Day 15.—

Secondary

MeasureTime frame
Literature Study Of Anartava. To Prepare Krishna Til And Gud A Modak To Observe Its Effect On Various Prakruti To Observe Its Effect On Endometrial Thickness And Menstruation Timepoint: Study Will Be Done Using Ayurvedic Granthas And Modern Texts. Preparation Of Drug Will Be Done According To Procedure. During Treatment Observation Of Effect Of Drug On Various Prakruti Will Be Noted.Its Effect On Endometrial Thickness And Menstruation Will Be Noted In The Present Cycle.—

Countries

India

Contacts

Public ContactDr Aashika Maheshkumar Prajapati

Sumatibhai Shah Ayurved Mahavidyalaya

mandaghorpade@yahoo.com9822007570

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026